HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- (3,4- dichlorophenyl)- 6- (methoxymethyl)- 4- azabicyclo(4.1.0)heptane

a triple reuptake inhibitor for serotonin, norepinephrine, and dopamine; structure in first source

Also Known As:

GSK1360707; GSK1360707F

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Aza Compounds: 3
  - Azabicyclo Compounds
    - 1-(3,4-dichlorophenyl)-6-(methoxymethyl)-4-azabicyclo(4.1.0)heptane: 1
Heterocyclic Compounds: 198
- Bridged-Ring Heterocyclic Compounds
  - Heterocyclic Bridged Bicyclo Compounds
    - Azabicyclo Compounds
      - 1-(3,4-dichlorophenyl)-6-(methoxymethyl)-4-azabicyclo(4.1.0)heptane: 1

Experts

1.	Bennacef, Idriss: 1 article (08/2013)
2.	Comley, Robert A: 1 article (08/2013)
3.	Gomeni, Roberto: 1 article (08/2013)
4.	Gray, Frank A: 1 article (08/2013)
5.	Gunn, Roger N: 1 article (08/2013)
6.	Iavarone, Laura: 1 article (08/2013)
7.	Laruelle, Marc: 1 article (08/2013)
8.	Marzano, Carmine: 1 article (08/2013)
9.	Neve, Marta: 1 article (08/2013)
10.	Petrone, Marcella: 1 article (08/2013)

Related Diseases

1.	Major Depressive Disorder (Major Depressive Disorders) 08/01/2013 - "GSK1360707 [(1R,6S)-1-(3,4-dichlorophenyl)-6-(methoxymethyl)-4-azabicyclo[4.1.0]heptane] is a novel TRI that until recently was under development for the treatment of major depressive disorder; its development was put on hold for strategic reasons. "

Related Drugs and Biologics

1.	Heptanes